Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G Focuses On Consumer Health, “Deemphasizes” Pharma

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble says consumer health trends are on its side as the company increases focus on its consumer health business and moves away from pharmaceuticals
Advertisement

Related Content

P&G Open To M&A Moves, Closed To Board Seat For Activist Investor
P&G Open To M&A Moves, Closed To Board Seat For Activist Investor
P&G Throws Weight Behind Consumer Growth After Shedding Pharma
P&G Pharma Sale Could Bring $1 Billion To Feed Consumer Business
Pfizer/Wyeth Merger Would Offer Diversification, Switch Outlet
J&J Exploring Growth Abroad, Charting Health And Wellness Strategy
Sea Changes In Regulation And The Market: Top Stories Of 2008
P&G Braces For “Tough Year” Of Navigating Turbulent Economy
Crest Pro-Health Benefits Squeezed Into Whitening Toothpaste
Crest Pro-Health Benefits Squeezed Into Whitening Toothpaste

Topics

Advertisement
UsernamePublicRestriction

Register

PS102415

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel